EUA
UCLA SwabSeq COVID-19 Diagnostic Platform
FDA Emergency Use Authorization · University of California, Los Angeles (UCLA) · Oct 8, 2020
Key facts
| Product | UCLA SwabSeq COVID-19 Diagnostic Platform |
|---|---|
| Company | University of California, Los Angeles (UCLA) |
| Product type | RT-PCR and Sequencing, Single Target |
| Date | Oct 8, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: